NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. NEOGEN's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

Company profile
Ticker
NEOG
Exchange
Website
CEO
John Adent
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
WHERE INCORPORATED • Abbott Analytical Limited • Abtek (Biologicals) Limited • Acumedia Manufacturers, Inc. • CAP IM Supply, LLC • CAP Supply, LLC • Chem-Tech, Ltd. • Delf Chem Solutions, Ltd. • Delf (UK) Limited • Falcon New OpCo, LLC ...
IRS number
382367843
NEOG stock data
Latest filings (excl ownership)
SD
Conflict minerals disclosure
30 May 23
8-K
Departure of Directors or Certain Officers
6 Apr 23
10-Q
2023 Q3
Quarterly report
4 Apr 23
8-K
Neogen Announces Third-Quarter 2023 Results
30 Mar 23
10-Q
2023 Q2
Quarterly report
9 Jan 23
8-K
Neogen Announces Second-Quarter 2023 Results
5 Jan 23
8-K
Regulation FD Disclosure
30 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
7 Oct 22
10-Q
2023 Q1
Quarterly report
30 Sep 22
8-K
Neogen Announces First Quarter Results
28 Sep 22
Transcripts
NEOG
Earnings call transcript
2023 Q3
30 Mar 23
NEOG
Earnings call transcript
2023 Q2
5 Jan 23
NEOG
Earnings call transcript
2023 Q1
27 Sep 22
NEOG
Earnings call transcript
2022 Q4
26 Jul 22
NEOG
Earnings call transcript
2021 Q3
24 Mar 22
NEOG
Earnings call transcript
2022 Q2
21 Dec 21
NEOG
Earnings call transcript
2022 Q1
21 Sep 21
NEOG
Earnings call transcript
2021 Q4
20 Jul 21
NEOG
Earnings call transcript
2021 Q3
23 Mar 21
NEOG
Earnings call transcript
2021 Q2
22 Dec 20
Latest ownership filings
4
Jason Warren Lilly
27 Apr 23
4
Jerome L Hagedorn
27 Apr 23
4
Douglas Edward Jones
27 Apr 23
4
JOHN EDWARD ADENT
27 Apr 23
SC 13G/A
SUSQUEHANNA SECURITIES, LLC
14 Feb 23
SC 13G/A
NORGES BANK
14 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
WASATCH ADVISORS INC
8 Feb 23
4
WILLIAM T BOEHM
30 Jan 23
SC 13G/A
BlackRock Inc.
23 Jan 23
Financial summary
Quarter (USD) | Feb 23 | Nov 22 | Aug 22 | May 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | May 22 | May 21 | May 20 | May 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 67.13 mm | 67.13 mm | 67.13 mm | 67.13 mm | 67.13 mm | 67.13 mm |
Cash burn (monthly) | 10.96 mm | (no burn) | (no burn) | (no burn) | 5.69 mm | 2.46 mm |
Cash used (since last report) | 35.62 mm | n/a | n/a | n/a | 18.50 mm | 8.01 mm |
Cash remaining | 31.52 mm | n/a | n/a | n/a | 48.64 mm | 59.13 mm |
Runway (months of cash) | 2.9 | n/a | n/a | n/a | 8.5 | 24.0 |
Institutional ownership, Q1 2023
97.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 351 |
Opened positions | 46 |
Closed positions | 62 |
Increased positions | 119 |
Reduced positions | 121 |
13F shares | Current |
---|---|
Total value | 3.73 tn |
Total shares | 209.76 mm |
Total puts | 241.60 k |
Total calls | 350.70 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 24.37 mm | $451.28 bn |
Vanguard | 18.53 mm | $343.26 bn |
Wasatch Advisors | 14.14 mm | $261.92 bn |
Susquehanna Securities | 8.29 mm | $0.00 |
Select Equity | 7.98 mm | $147.85 bn |
STT State Street | 7.56 mm | $140.09 bn |
Brown Capital Management | 5.85 mm | $108.26 bn |
King Luther Capital Management | 5.80 mm | $107.40 bn |
MS Morgan Stanley | 5.78 mm | $107.00 bn |
Conestoga Capital Advisors | 5.70 mm | $105.54 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Apr 23 | Adent John Edward | Common Stock | Payment of exercise | Dispose F | No | No | 16.67 | 656 | 10.94 k | 81,907 |
25 Apr 23 | Douglas Edward Jones | Common Stock | Payment of exercise | Dispose F | No | No | 16.67 | 297 | 4.95 k | 11,857 |
25 Apr 23 | Jerome L Hagedorn | Common Stock | Payment of exercise | Dispose F | No | No | 16.67 | 194 | 3.23 k | 2,571 |
25 Apr 23 | Lilly Jason Warren | Common Stock | Payment of exercise | Dispose F | No | No | 16.67 | 388 | 6.47 k | 21,506 |
26 Jan 23 | William T Boehm | Common Stock | Option exercise | Dispose M | No | No | 20.08 | 750 | 15.06 k | 24,509 |
26 Jan 23 | William T Boehm | Common Stock | Option exercise | Acquire M | No | No | 15.62 | 1,500 | 23.43 k | 25,259 |
26 Jan 23 | William T Boehm | Common Stock Common Stock | Option exercise | Dispose M | No | No | 15.62 | 1,500 | 23.43 k | 66,667 |
News
Neogen Launches New Assays For Histamine Detection
31 May 23
Earnings Scheduled For March 30, 2023
30 Mar 23
Neogen Q3 Adjusted EPS $0.12 May Not Compare To $(0.01) Estimate, Sales $218.25M Miss $218.86M Estimate
30 Mar 23
Electronic Arts, Manchester United And 3 Stocks To Watch Heading Into Thursday
30 Mar 23
Investor Fear Eases Following Surge In Tech Stocks
30 Mar 23
Press releases
Neogen® Launches New Assays for Histamine Detection
31 May 23
Neogen® to Participate in the 43rd Annual William Blair Growth Stock Conference
30 May 23
Neogen® Launches New Assays for Natural Toxin Detection
9 May 23
Neogen Announces Third-Quarter 2023 Results
30 Mar 23
Neogen® Viroxide Super™ Receives New Label Claims in U.S. and Canada
21 Mar 23